Neuroscience Experts from GSK, Eli Lilly and Janssen Meet in Search for Alzheimer’s Cure

Alzheimer’s GSK to provide a keynote address on delivering macromolecules across the blood brain barrier at Alzheimer’s industry meeting next May The GSK presentation will review challenges of macromolecule distribution and will ask the question: How can we measure CNS penetration? — SMi Group LONDON, ENGLAND, UNITED KINGDOM, March 22, 2016 /EINPresswire.com/ — SMi Group are delighted to have Steve Hood, Director of Biotransformation & Drug Deposition from GSK, present a keynote address at Alzheimers 2016 when it arrives to London on 10th & 11th May 2016.With a focus on small molecule drugs, the presentation will review challenges of macromolecule distribution and will ask the question: How can we measure CNS penetration? With collaborative research being a key emphasis of GSK, the European partnership “COMPACT” will also be introduced to…


Link to Full Article: Neuroscience Experts from GSK, Eli Lilly and Janssen Meet in Search for Alzheimer’s Cure

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!